A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Rifapentine
Dexchlorpheniramine maleate
The metabolism of Fesoterodine can be decreased when combined with Dexchlorpheniramine maleate.
Rifapentine
Melperone
The metabolism of Fesoterodine can be decreased when combined with Melperone.
Rifapentine
Lenvatinib
The metabolism of Fesoterodine can be decreased when combined with Lenvatinib.
Rifapentine
Sparteine
The metabolism of Fesoterodine can be decreased when combined with Sparteine.
Rifapentine
Vernakalant
The metabolism of Fesoterodine can be decreased when combined with Vernakalant.
Rifapentine
Rotigotine
The metabolism of Fesoterodine can be decreased when combined with Rotigotine.
Rifapentine
Dapoxetine
The metabolism of Fesoterodine can be decreased when combined with Dapoxetine.
Rifapentine
Iproniazid
The metabolism of Fesoterodine can be decreased when combined with Iproniazid.
Rifapentine
Rilpivirine
The metabolism of Rilpivirine can be decreased when combined with Fesoterodine.
Rifapentine
Levosalbutamol
The metabolism of Levosalbutamol can be decreased when combined with Fesoterodine.
Rifapentine
Metreleptin
The metabolism of Fesoterodine can be increased when combined with Metreleptin.
Rifapentine
Potassium cation
Potassium cation may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Ertugliflozin
Ertugliflozin may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Canagliflozin
Fesoterodine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Efonidipine
Efonidipine may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Drospirenone
Drospirenone may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Potassium
Potassium may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Bromotheophylline
Bromotheophylline may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Xipamide
Xipamide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine
Muzolimine
Muzolimine may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3